维普中文期刊产品整合服务
31篇 您的检索式:作者名="Llorca PM"
    题名 作者 年代 出处 被引量
1Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications显示文摘 Llorca PM Lancon C 2002Encephale2002,28,31:1
2Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies 显示文摘MOLLER HJ LLORCA PM SACCHETTI E 2005Int Clin Psychopharmacol2005,20,3:1
3Partial compliance in schizophrenia and the impact on patient outcomes显示文摘Llorca PM 2008Psychiatry Res2008,161,2:1
4Partial compliance in schizophrenia and the impact on pat ient outcomes显示文摘Llorca PM 0,,02:1
5Cost-effectiveness analysis of schizophrenic patient care settings:impact of an atypical antipsychotic under long-acting injection formulation显示文摘LLORCA PM MIADI-FARGIER H LANCON C 2005Encephade2005,31,2:1
6Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipaychotic therapies显示文摘MOLLER HJ LLORCA PM SACCHETTI E 2005Int Clin Psychopharmacol2005,20,3:1
7Partial compliance in schizophrenia and the impact on patient outcomes显示文摘Llorca PM 2008Psychiatry Res2008,161,2:1
8Escitalopram for treatment of major depressive disorder in adults显示文摘Llorca PM Brousse G Schwan R 0,,4:1
9Partial compliance in schizophrenia and the impact on patient outcomes 显示文摘Llorca PM 2008Psychiatry Res2008,161,2:1
10Escitalopram for treatment of major depressive disorder in adults显示文摘Llorca PM Brousse G Schwan R 0,,4:1
11Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone 显示文摘LLORCA PM BOUHOURS P MOREAU-MALLET V 2008Encephale2008,34,2:1
12Comparison of escitalopram and citalopram efficacy:a meta-analysis显示文摘Auquier P Robitail S Llorca PM 2003Int J Psychiatry Clin Pract2003,7,:1
13Optimizing treatment of schizophrenia to minimize relapse显示文摘Samalin L Blanc O Llorca PM 2010Expert Rev Neurother2010,10,2:1
14Escitalopram for treatment of major depressive disorder in adults显示文摘Llorca PM Brousse G Schwan R 2005Encephale2005,31,41:1
15Partial compliance in schizophrenia and the impact on patient outcomes显示文摘Llorca PM 2008Psychiatry Research2008,161,2:1
16Partial complimace in schizophrenia and the impact on patient outcomes 显示文摘Llorca PM 2008Psychiatry Res2008,161,2:1
17Optimizing treatment of schizophrenia to minimize relapse显示文摘Samalin L Blanc O Llorca PM 2010Expert Rev Neurother2010,10,2:1
18Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial显示文摘DAVIDSON JR WITTCHEN HU LLORCA PM 2008Eur Neuropsyehopharmaeol2008,18,9:1
19A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design显示文摘LLORCA PM BODKIN JA SPANN M et d 2009J Clin Psychoph- armacol2009,29,1:1
20Efficacy and safety of direct transition to dsperidone long-acting injectable in patients treated with various anfipsychotic therapies 显示文摘M/Jller I-IJ Llorca PM Sacchetti E 2005Int Clin Psychopharmacol2005,20,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费